Sarepta Therapeutics, Inc. (SRPT) revenue & profit
Sarepta Therapeutics, Inc. (SRPT): revenue $2.2B, net income -$713.4M in 2025; latest quarter -34.3% year over year. From SEC filings.
$2.2BRevenue 2025
TickerSRPT (Nasdaq)
IndustryOther
Revenue 2025$2.2B
Net income 2025-$713.4M
Net margin-32.5%
Annual revenue growth+15.6%
Latest quarter (2026 Q2) · Revenue$401.3M
vs. same quarter last year-34.3%
Latest quarter · Net income-$4.9M
Annual revenue & net income
| Year | Revenue | Net income | |
|---|---|---|---|
| 2022 | $933M | -$703.5M | |
| 2023 | $1.2B | -$536M | |
| 2024 | $1.9B | $235.2M | |
| 2025 | $2.2B | -$713.4M |
ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.